NCT01240759 - Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy | Biotech Hunter

Enrollment

218

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

December 31, 2011

Study Completion Date

January 31, 2012

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG

S-707106 Dose A

One S-707106 A tablet

DRUG

S-707106 Dose B

One S-707106 B tablet

DRUG

S-707106 Dose C

Four S-707106 4 X B tablets

DRUG

Placebo A tablet

Up to 4 Placebo A tablets

DRUG

Metformin

The standard of care dose of metformin for each patient

Trial Locations (1)

Juno Research, LLC, Houston